News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
AtheroGenics Cuts 50% of Jobs to Focus on Heart Drug
May 25, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 25 (Reuters) - Drug company AtheroGenics Inc. cut about 50 percent of its workforce in what it said was a first step in new plans for its failed heart drug AGI-1067, it said in a regulatory filing.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
MORE ON THIS TOPIC
Layoff Tracker
AC Immune To Cut 30% of Workforce
September 5, 2025
·
196 min read
·
BioSpace Editorial Staff
Job Trends
Silver Linings: When Getting Laid Off Has an Upside
September 4, 2025
·
5 min read
·
Angela Gabriel
Career Advice
The Top 12 Companies Hiring in Biopharma Now
September 4, 2025
·
1 min read
·
Angela Gabriel
Job Trends
Data Scientist Fourth Fastest-Growing U.S. Job, Says BLS
September 3, 2025
·
2 min read
·
Angela Gabriel
